This HTML5 document contains 148 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n10http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37702336
rdf:type
wikibase:Item
schema:description
научни чланак vedecký článok articolo scientifico scientific article published on 24 March 2014 vědecký článek vetenskaplig artikel artigo científico artículu científicu espublizáu en 2014 wetenschappelijk artikel наукова стаття, опублікована в березні 2014 مقالة علمية نشرت في 24 مارس 2014 wissenschaftlicher Artikel article científic videnskabelig artikel bilimsel makale article scientifique
p:P577
wds:Q37702336-C31A3DAD-E1DD-44C2-B01E-108F7888965E
wdt:P577
2014-03-24T00:00:00Z
p:P407
wds:Q37702336-05B667A5-F75E-4EA7-ADC3-5D4C5944B0AD
wdt:P407
wd:Q1860
p:P2860
wds:Q37702336-DABB46F5-CAD6-4F31-BCC7-EF43321315E0 wds:Q37702336-E9FDC9B1-0186-4D00-A66C-5F934B8226D7 wds:Q37702336-4DDE08A8-C668-4544-B060-8EE78E198872 wds:Q37702336-635246A4-0BE0-441D-B0E0-FD05ED811976 wds:Q37702336-6F018083-9C8D-483B-A77E-2F231D84EC17 wds:Q37702336-79E0B0A9-4FED-48E6-9A87-DF65446B08A2 wds:Q37702336-9006E50A-07B7-47F9-A165-385FDC8B3684 wds:Q37702336-9B661FA9-AAEE-467A-9435-96D12178722E wds:Q37702336-9BD30255-7811-4F49-8D2A-C13A6D9189F3 wds:Q37702336-9C7985DF-A763-4B85-B4B9-73036697328D wds:Q37702336-18BEE5B0-226F-4AB1-BC8F-1FEB71B0F316 wds:Q37702336-1EBE127A-EE2A-44D0-A1BE-687F9C000B66 wds:Q37702336-202E41CE-02F5-414A-9799-60E331E94EED wds:Q37702336-2138684D-6DBF-4BA9-84E7-99C5226EFEC0 wds:Q37702336-2BDE84C5-8E76-42B0-98B4-12AE86B7E154 wds:Q37702336-334BA0FD-2E8F-4210-AE2D-D78D044CA67E wds:Q37702336-3CF21D2E-AC1C-45CE-B6B4-030418D10B79 wds:Q37702336-3D37CF49-A5D6-4CB9-942A-43CF240655D9 wds:Q37702336-43BAB794-0A20-4C35-95D3-051FEC2D1E01 wds:Q37702336-490D0226-DA01-407C-9501-C95B3BFEB4EC wds:Q37702336-020FF01F-7BDE-4FCD-BE9C-E18C7322503E wds:Q37702336-0FAA272E-5DE5-4B2A-A990-74609729ED0D wds:Q37702336-EFA4E22E-76AE-49B4-81B0-346E23E09BC4 wds:Q37702336-F11E9D37-8260-41D4-881B-A8BE1A313F4E wds:Q37702336-FD34D9E5-310B-46E0-BCD7-DDD0A1D407B4 wds:Q37702336-9F335D96-540A-472D-AF33-F52B1B823CB6 wds:Q37702336-C2E2C367-57FB-43DB-A946-B9BF8D03D91F
wdt:P2860
wd:Q28305247 wd:Q34433577 wd:Q80538299 wd:Q37372837 wd:Q34615087 wd:Q34060237 wd:Q28301602 wd:Q39361860 wd:Q22299206 wd:Q34559054 wd:Q24563021 wd:Q40737646 wd:Q36259209 wd:Q34128471 wd:Q37277999 wd:Q37454125 wd:Q35848726 wd:Q29615066 wd:Q79734535 wd:Q37086937 wd:Q29617274 wd:Q36338031 wd:Q37396081 wd:Q33628772 wd:Q29547853 wd:Q46102907 wd:Q35750919
p:P2093
wds:Q37702336-84E17A3B-2793-4B1C-BA10-A0F1A9A66A91 wds:Q37702336-BD67427F-AE6A-40DD-ABFC-E53BC12C2944 wds:Q37702336-E827E651-B37F-44B2-9086-803B7523DA56 wds:Q37702336-C965E5C4-1D1C-4A67-A728-6B4A72FED76B wds:Q37702336-21038D79-7644-4B40-959B-D3081279D560 wds:Q37702336-35DFF729-342C-4245-B88F-35DB8C4FC6AB wds:Q37702336-5869961D-E890-40BD-A29B-BD93E44A920A wds:Q37702336-54D3C020-C905-4A27-85E2-870BE7C68B7E wds:Q37702336-867E20C9-CD2E-46B0-B3E2-585D3941BE9A wds:Q37702336-EE55084F-9F8B-4117-B848-36C4D0674636
wdt:P2093
Ari Melnick James Herman Janice Gabrilove Peter L Greenberg Mark Juckett Martin S Tallman Harry P Erba Lisa Malick Steven D Gore Zhuoxin Sun
rdfs:label
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905. Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905. Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905.
skos:prefLabel
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905. Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905. Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905.
schema:name
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905. Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905. Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905.
p:P50
wds:Q37702336-7DF79583-869E-4590-851D-3CDB0774836C wds:Q37702336-ED6CD91F-01B2-444E-9491-0A1D9DFBA1AA wds:Q37702336-D512D38C-F6AC-4B0D-B300-03BB2FCE7214 wds:Q37702336-AE624225-09AF-4EB2-8D59-97EE4D32E166 wds:Q37702336-0F4C0ACE-62CC-4630-A36D-89C92C77B2E1 wds:Q37702336-0FB8BED0-33FC-4528-9802-80C3CD796FCD wds:Q37702336-0AE2E152-CD73-4AB7-B410-E21B0B971539
wdt:P50
wd:Q46177716 wd:Q87294607 wd:Q69071275 wd:Q47320517 wd:Q61111749 wd:Q37841068 wd:Q89701348
p:P1476
wds:Q37702336-C8FE0B0B-C30D-4691-83B6-2B56F5A54319
wdt:P1476
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905.
p:P304
wds:Q37702336-E77502C2-F662-4876-B164-BA3C0276D9FD
wdt:P304
1242-1248
p:P31
wds:Q37702336-DEE86AAF-6468-4E59-804A-DC367749030C
wdt:P31
wd:Q13442814
p:P921
wds:Q37702336-2A0B6340-0E05-4706-9C7C-B11B168C03EE wds:Q37702336-15B61279-26D9-489A-AB7F-19C6F398C1F4 wds:Q37702336-ADA0CCA0-0F41-4752-98F1-0AFDFC57E6B1 wds:Q37702336-646719C1-DEED-4DB2-99C4-6CFD6A1F5499 wds:Q37702336-78332B4D-484E-454B-8361-01A4421F58A0
wdt:P921
wd:Q29496 wd:Q53910821 wd:Q264118 wd:Q1281020 wd:Q954625
p:P698
wds:Q37702336-8CA2F092-9E00-4E45-A8D5-EC716EF5D90A
wdtn:P698
n11:24663049
wdt:P698
24663049
p:P1433
wds:Q37702336-2FF57C10-3956-4ABB-9BCD-9F5A5130C9AC
wdt:P1433
wd:Q400292
p:P433
wds:Q37702336-1403EBDA-303A-4288-ADEA-F90C0E97510C
p:P478
wds:Q37702336-1627294D-77DB-4453-A3AC-59BD500720BB
wdt:P433
12
wdt:P478
32
p:P356
wds:Q37702336-E72091F3-DE3E-492E-9BFC-969075475D53
wdtn:P356
n10:JCO.2013.50.3102
wdt:P356
10.1200/JCO.2013.50.3102
p:P932
wds:Q37702336-B6E729F6-98C1-46FF-AF59-0C839069EA65
wdt:P932
3986386